Jack Huang

Dec 3, 2024 | drugdiscoveryonline.com | Jack Huang

Even when induced pluripotent stem cells (iPSCs) are derived from the patient's cells, immune rejection can still occur. This article explores the causes as well as strategies to overcome immune rejection. Guidelines To Bring Your Drug To Market: Are You Prepared? Are you up to the task of bringing a biologic drug to market? Do you have a strategy and plan for moving forward? Here, we explore this from a biopharma process development and manufacturing perspective.

Nov 6, 2024 | cellandgene.com | Jack Huang

By Jack (Jie) Huang, MD, Ph.D., chief scientist, founder/CEO, CSTEAM biotechnology Induced pluripotent stem cells (iPSCs) have revolutionized regenerative medicine and gene therapy, providing a groundbreaking approach to create patient-specific cells that can be genetically corrected and differentiated into virtually any cell type.1 This technology promises transformative applications in a range of diseases, from genetic disorders and neurodegenerative diseases to cardiovascular disease and...

Oct 16, 2024 | nature.com | Jack Huang |John Torous

AbstractTechnology is playing an increasing role in healthcare, especially in mental health. Traditional mental healthcare, whether in-person or via telehealth, cannot by itself address the massive need for services. Standalone technology such as smartphone apps, while easily accessible, have seen limited engagement and efficacy on their own.

Jun 1, 2024 | caribbeannewsglobal.com | Jack Huang

By Jack HuangThe reality of an international world filled with conflictsTaiwan is an indispensable partner in the international community’s implementation of sustainable development goals. From both a geopolitical perspective and economic performance, Taiwan plays a crucial role. According to , Taiwan, after adjusting for purchasing power parity (PPP) and gross domestic product (GDP), ranked 14th among 193 countries and territories, surpassing Japan and South Korea in Asia.